Drug Search Results

Naronapride

Alternative Names: naronapride, ati-7505, ati7505, ati 7505
Latest Update: 2024-08-27
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: 5-HT4 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Procter and Gamble
Company Location: CINCINNATI OH 45202
Company CEO: Jon R. Moeller
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Naronapride

Countries in Clinic: Austria, Belgium, France, Germany, Italy, Latvia, Netherlands, Poland

Active Clinical Trial Count: 3

Highest Development Phases

Phase 2: Gastroparesis

Trial	Phase	Trial Status	Disease	Primary Completion Date
NAT-19/GPX	P2	Unknown Status	Gastroparesis	2025-03-15
MOVE-IT	P2	Recruiting	Gastroparesis	2025-01-01
2021-002254-86	P2	Active, not recruiting	Gastroparesis	2024-09-26

Recent News Events

Date	Type	Title
08/13/2024	News Article	Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Expansion of the Phase 2b MOVE-IT Study of Naronapride in Gastroparesis and Dosing of the First United States Patient
03/27/2024	News Article	Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Drug Application for Naronapride to Treat Gastroparesis and Subsequent Expansion of the Ongoing Phase 2b MOVE-IT Study to the United States
02/07/2024	News Article	Renexxion Ireland's European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomatic GERD as the Second Naronapride Indication to Develop and Commercialize in their Licensed Territories
02/01/2024	News Article	Renexxion to Present at the Oppenheimer 34ᵗʰ Annual Healthcare Life Sciences Conference
12/01/2022	PubMed	Pharmacotherapeutic advances for chronic idiopathic constipation in adults.
04/01/2021	PubMed	Prokinetic actions of luminally acting 5-HT4 receptor agonists.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions